Oxford Cannabinoid Technologies Signs Deal for Phase 1 Trials,

Medicines & Healthcare products Regulatory Agency and the U.S. Food and Drug Administration, it added. Shares at 0721 GMT were up 0.15 pence, or …, Medicines & Healthcare products Regulatory Agency and the U.S. Food and Drug Administration, it added. Shares at 0721 GMT were up 0.15 pence, or …, Read More

Scroll to Top